Infection by Helicobacter pylori and acute myocardial infarction. Do cytotoxic strains make a difference?

New Microbiologica

Volumn 25, Issue 3, 2002, Pages 315-321

  Pellicano, R ^a   Parravicini, P P ^b   Bigi, R ^b   Gandolfo, N ^c   Aruta, E ^d   Gai, V ^a   Figura, N ^e   Angelino, P ^f   Rizzetto, M ^a   Ponzetto, A ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b Morelli Hospital   (Italy)

^c MAURIZIANO HOSPITAL   (Italy)

^d S GIOVANNI BOSCO HOSPITAL   (Italy)

^e UNIVERSITY OF SIENA   (Italy)

^f Cardiology Rivoli Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CAGA PROTEIN, HELICOBACTER PYLORI; FIBRINOGEN;

ADULT; AGE; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; HEART INFARCTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HYPERGLYCEMIA; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOGENICITY; PREVALENCE; RISK FACTOR; VIRULENCE; WESTERN BLOTTING;

ADULT; AGE FACTORS; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; FIBRINOGEN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; RISK FACTORS; VIRULENCE;

EID: 0036653286     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. BIRNIE, D.H., HOLME, E.R., MCKAY, I.C., HOOD, S., MCCOLL, K.E.L., and HILLIS, W.S. (1998) Association between antibodies to heat shock protein 65 and coronary atherosclerosis. European Heart Journal, 19, 387-394.
2. BLASI, R., DENTI, F., ERBA, M., COSENTI, R., RACCANELLI, R., RINALDI, A., FAGETTI, L., ESPOSITO, E., RUBERTI, U., and ALLEGRA, L. (1996). Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. Journal of Clinical Microbiology, 34, 2766-2769.
3. BRAUNWALD, E. (1997). Shattuck letture- Cardiovascular medicine at the turn of the millenium: triumphs, concerns and opportunities. New England Journal of Medicine, 337, 1360-1369
4. DANESH, J., YOUNGMAN, L., CLARK, S., PARISH, S., PETO, R., and COLLINS, R. (1999). Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study. British Medical Journal, 319, 1157-1162.
5. DANESH, J., and PETO, R. (1998). Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. British Medical Journal, 316, 1130-1132.
6. DANIELLI, E. (1993). A fluorometric enzymelinked immunosorbent assay for serological diagnosis of Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology, 5 (S2). S57-S59.
7. DE Luis, D.A., SAN ROMAN, A.L., LAHERA, M., ALLER, R., CANTON, R., DE LA CALLE, H., and BOIXEDA, D. (1998). Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients. Diabetes Care, 21, 1129-1132.
8. ELIZALDE, J.I., GOMEZ, J., PANES, J., LOZANO, M., CASADEVALL, M., RAMIREZ, J., PIZCUETA, P., MARCO, F., DIAZ DE ROJAS, F., GRANGER, D.N.. and PIOUÉ, J.M. (1997). Platelet activation in mice and human Helicobacter pylori infection. Journal of Clinical Investigation, 100, 996-1005.
9. FARSAK, B., YILDIRIR, A., AKYON, Y., PINAR, A., OC, M., BOKE, E., KES, S., and TOKGOZOGLU, L. (2000). Detection of Chlamydia pneumoniae and Helicobacter pylori in human atherosclerotic plaques by PCR. Journal of Clinical Microbiology, 38, 4408-4411.
10. GUELI, N., DEL NERO, A., ZIA, N., CARMENINI, E., and CARMENINI, G. (2000). Life habits and cardiovascular risk in a group of bank employees in Rome. Panminerva Medica, 41, 187-192.
11. GUNN, M., STEPHENS, J.C., THOMPSON, J.R., RATHBONE, B.J., and SAMANI, N.J. (2000). Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart, 84, 267-271.
12. GUPTA, S., LEATHAM, E.W., CARRINGTON, D., MENDALL, M.A., KASKI, J.C., and CAMM, A.J. (1997). Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivor of myocardial infarction. Circulation, 96, 404-407.
13. GURFINKEL, E., BOZOVICH, G., DAROCA, A., BECK, E., and MAUTNER, B. (1997). Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet, 350, 404-407.
14. HOFFMEISTER, A., ROTHENBACHER, D., BODE, G., PERSSON, K., MARZ, W., NAUCK, M.A., BRENNER, H., HOMBACH, V., and KOENIG, W. (2001). Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus is associated with an atherogenic, modified lipid profile. Arteriosclerosis Thrombosis Vascular Biology, 21, 427-432.
15. KAHAN, T., LUNDMAN, P., OLSSON, G., and WENDT, M. (2000). Greater than normal prevalence of seropositivity for Helicobacter pylori among patients who have suffered myocardial infarction. Coronary Artery Disease, 11, 523-526.
16. MARTIN DE ARGILA, C., BOIXEDA, D., and CANTON, R. (1995). High seroprevalence of Helicobacter pylori infection in coronary heart disease, (letter) Lancet, 346, 310.
17. MATTILA, K.J., VALTONEN, V.V., NIEMINEN, M.S., and ASIKAINEN, S. (1998). Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clinical Infectious Diseases, 26, 719-734.
18. MENDALL, M.A., GOGGIN, P.M., MOLINEAUX, N., LEVY, J., TOOSY, T., STRACHAN, D., and CAMM, A.J. (1994). Relation of Helicobacter pylori infection and coronary heart disease. British Heart Journal, 71, 437-439.
19. MENDALL, M.A., GOGGIN, P.M., MOLINEAUX, N., LEVY, J., TOOSY, T., STRACHAN, D., and NORTHFIELD, T.C. (1992). Association between childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet, i, 896-897.
20. MURRAY, C.J.L., and LOPEZ, A.D. (1997). Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet, 349, 1269-1276.
21. MURRAY, L.J., BAMFORD, K.B., KEE, F., MCMASTER, D., CAMBIEN, F., DALLONGEVILLE, J., and EVANS, A. (2000). Infection with virulent strains of Helicobacter pylori is not associated with ischaemic heart disease: evidence from a population-based case-control study of myocardial infarction. Atherosclerosis, 149, 379-385.
22. PARENTE, F., IMBESI, V., CUCTNO, C., MACONI, G., Russo, U., DUCA, P.G., and BIANCHI PORRO, G. (2000). Helicobacter pylori CagA seropositivity does not influence inflammatory parameters, lipid concentrations and haemostatic factors in healthy individuals. Journal of Internal Medicine, 247, 213-217.
23. PASCERI, V., CAMMAROTA, G., PATTI, G., CUOCO, L., GASBARRINI, A., GRILLO, R.L., FEDELI, G., GASBARRINI, G., and MASERI, A. (1998). Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation, 97, 1675-1679.
24. PATEL, P., CARRINGTON, D., STRACHAN, D., LEATHAM, E., GOGGIN, P., NORTHFIELD, T.C., and MENDALL, M.A. (1994). Fibrinogen: a link between chronic infection and coronary heart disease. Lancet, 343, 1634-1635.
25. PELLICANO, R., OLIARO, E., GANDOLFO, N., ARUTA, E., MANGIARDI, L., ORZAN, F., BERGERONE, S., RIZZETTO, M., and PONZETTO, A. (2000). Ischemic cardiovascular disease and Helicobacter pylori. Where is the link. Journal of Cardiovascular Surgery, 41, 829-833.
26. PELLICANO, R., MAZZARELLO, M.G., MORELLONI, S., ALLEGRI, M., ARENA, V., FERRARI, M., RIZZETTO, M., and PONZETTO, A. (1999). Acute myocardial infarction and Helicobacter pylori seropositivity. International Journal of Clinical & Laboratory Research, 29, 141-144.
27. PELLICANO, R., RIZZETTO, M., and PONZETTO, A. (2001). Helicobacter pylori infection and coronary heart disease. A continuously debated question. Panminerva Medico, 43, 139-140.
28. REPORT OF THE JOINT INTERNATIONAL SOCIETY AND FEDERATION OF CARDIOLOGY/WORLD HEALTH ORGANIZATION TASK FORCE ON STANDARDIZATION OF CLINICAL NOMENCLATURE (1979). Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation, 59, 607-608.
29. Ross, R. (1999). Atherosclerosis- An inflammatory disease New England Journal of Medicine, 340, 115-126.
30. RUPPRECHT, H.J., BLANKENBERG, S., BICKEL, C., RIPPIN, G., HAFNER, G., PRELLWITZ, W., SCHLUMBERGER, W., and MEYER, J. (2001). Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation, 104, 25-31.
31. SHAPER, A.G., POCOCK, S.J., WALKER, M., PHILLIPS, A.N., WHITEHEAD, T.P., and MACFARLANE, P.W. (1985). Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. Journal of Epidemiology and Community Health, 39, 197-209.
32. SUNG, J.J.Y., and SANDERSON, J.E. (1996). Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease Heart, 76, 305-307.
33. WHINCUP, P.H., MENDALL, M.A., PERRY, I.J., STRACHAN, D., and WALKER, M. (1996). Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart, 75, 568-572.
34. WHINCUP, P.H., DANESH, J., WALKER, M., LENNON, L., THOMSON, A., APPLEBY, P., HAWKEY, C., and ATHERTON, J. (2000). Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation, 101, 1647-1652.